Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Perini

Showing results (21-30 of 77) with videos related to

Pageof 8
Sort By:
The Journal of Experimental Medicine|April 3, 2002
Role of p75 neurotrophin receptor in the neurotoxicity by beta-amyloid peptides and synergistic effect of inflammatory cytokinesGiovanni Perini, Vittorina Della-Bianca, Valeria Politi, et al.
Genes|May 21, 2020
Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological ActionabilityGiorgio Milazzo, Daniele Mercatelli, Giulia Di Muzio, et al.
Oncotarget|June 12, 2015
Lysine-specific demethylase (LSD1/KDM1A) and MYCN cooperatively repress tumor suppressor genes in neuroblastomaStefano Amente, Giorgio Milazzo, Maria Cristina Sorrentino, et al.
Haematologica|April 12, 2012
A critical appraisal of tools available for monitoring epigenetic changes in clinical samples from patients with myeloid malignanciesKirsten Grønbæk, Carsten Müller-Tidow, Giovanni Perini, et al.
Cancer Letters|April 7, 2015
SKP2 is a direct transcriptional target of MYCN and a potential therapeutic target in neuroblastomaLaura Evans, Lindi Chen, Giorgio Milazzo, et al.
International Journal of Molecular Sciences|December 10, 2021
Targeting Oncogenic Transcriptional Networks in Neuroblastoma: From N-Myc to Epigenetic DrugsRoberto Ciaccio, Piergiuseppe De Rosa, Sara Aloisi, et al.
The Journal of Biological Chemistry|January 31, 2013
Physical interaction between MYCN oncogene and polycomb repressive complex 2 (PRC2) in neuroblastoma: functional and therapeutic implicationsDaisy Corvetta, Olesya Chayka, Samuele Gherardi, et al.
Human Molecular Genetics|January 27, 2011
APP-dependent up-regulation of Ptch1 underlies proliferation impairment of neural precursors in Down syndromeStefania Trazzi, Valentina Maria Mitrugno, Emanuele Valli, et al.
Cancer Research|February 11, 2010
p53 is a direct transcriptional target of MYCN in neuroblastomaLindi Chen, Nunzio Iraci, Samuele Gherardi, et al.
International Journal of Molecular Sciences|March 29, 2023
<i>MYCN</i> Amplification, along with Wild-Type RB1 Expression, Enhances CDK4/6 Inhibitors' Efficacy in Neuroblastoma CellsPiergiuseppe De Rosa, Federica Severi, Suleman Khan Zadran, et al.
Pageof 8

Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
The Journal of Experimental Medicine|April 3, 2002
Role of p75 neurotrophin receptor in the neurotoxicity by beta-amyloid peptides and synergistic effect of inflammatory cytokinesGiovanni Perini, Vittorina Della-Bianca, Valeria Politi, et al.
Genes|May 21, 2020
Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological ActionabilityGiorgio Milazzo, Daniele Mercatelli, Giulia Di Muzio, et al.
Oncotarget|June 12, 2015
Lysine-specific demethylase (LSD1/KDM1A) and MYCN cooperatively repress tumor suppressor genes in neuroblastomaStefano Amente, Giorgio Milazzo, Maria Cristina Sorrentino, et al.
Haematologica|April 12, 2012
A critical appraisal of tools available for monitoring epigenetic changes in clinical samples from patients with myeloid malignanciesKirsten Grønbæk, Carsten Müller-Tidow, Giovanni Perini, et al.
Cancer Letters|April 7, 2015
SKP2 is a direct transcriptional target of MYCN and a potential therapeutic target in neuroblastomaLaura Evans, Lindi Chen, Giorgio Milazzo, et al.
International Journal of Molecular Sciences|December 10, 2021
Targeting Oncogenic Transcriptional Networks in Neuroblastoma: From N-Myc to Epigenetic DrugsRoberto Ciaccio, Piergiuseppe De Rosa, Sara Aloisi, et al.
The Journal of Biological Chemistry|January 31, 2013
Physical interaction between MYCN oncogene and polycomb repressive complex 2 (PRC2) in neuroblastoma: functional and therapeutic implicationsDaisy Corvetta, Olesya Chayka, Samuele Gherardi, et al.
Human Molecular Genetics|January 27, 2011
APP-dependent up-regulation of Ptch1 underlies proliferation impairment of neural precursors in Down syndromeStefania Trazzi, Valentina Maria Mitrugno, Emanuele Valli, et al.
Cancer Research|February 11, 2010
p53 is a direct transcriptional target of MYCN in neuroblastomaLindi Chen, Nunzio Iraci, Samuele Gherardi, et al.
International Journal of Molecular Sciences|March 29, 2023
<i>MYCN</i> Amplification, along with Wild-Type RB1 Expression, Enhances CDK4/6 Inhibitors' Efficacy in Neuroblastoma CellsPiergiuseppe De Rosa, Federica Severi, Suleman Khan Zadran, et al.
Pageof 8